BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behl T, Kaur G, Sehgal A, Bhardwaj S, Singh S, Buhas C, Judea-Pusta C, Uivarosan D, Munteanu MA, Bungau S. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives. Int J Mol Sci 2021;22:1413. [PMID: 33573368 DOI: 10.3390/ijms22031413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Behl T, Kaur I, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Bumbu AG, Andronie-Cioara FL, Nechifor AC, Gitea D, Bungau AF, Toma MM, Bungau SG. The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications. Int J Mol Sci 2021;22:6737. [PMID: 34201647 DOI: 10.3390/ijms22136737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Behl T, Kaur G, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Bungau SG, Munteanu MA, Brisc MC, Andronie-Cioara FL, Brisc C. Elucidating the Multi-Targeted Role of Nutraceuticals: A Complementary Therapy to Starve Neurodegenerative Diseases. Int J Mol Sci 2021;22:4045. [PMID: 33919895 DOI: 10.3390/ijms22084045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Alexaki VI. The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives. Cells 2021;10:1584. [PMID: 34201844 DOI: 10.3390/cells10071584] [Reference Citation Analysis]
4 Zhao F, Luo Y. Potential Protective Effect of Dl-3-n-butylphthalide on Chronic Cerebral Ischemia Brain Injury. CNS Neurol Disord Drug Targets 2022;21:734-7. [PMID: 34939552 DOI: 10.2174/1871527321666211221160922] [Reference Citation Analysis]
5 Wang S, Zou F, Wu S, Wu Y, Yue Y, Sun Z. Neurotrophic factor levels in the serum and cerebrospinal fluid of neonates infected with human cytomegalovirus. Microbiol Immunol 2021;65:373-82. [PMID: 34019717 DOI: 10.1111/1348-0421.12918] [Reference Citation Analysis]
6 Wan J, Zhang G, Li X, Qiu X, Ouyang J, Dai J, Min S. Matrix Metalloproteinase 3: A Promoting and Destabilizing Factor in the Pathogenesis of Disease and Cell Differentiation. Front Physiol 2021;12:663978. [PMID: 34276395 DOI: 10.3389/fphys.2021.663978] [Reference Citation Analysis]
7 Kang H, Shin HJ, An HS, Jin Z, Lee JY, Lee J, Kim KE, Jeong EA, Choi KY, McLean C, Lee KH, Kim SK, Lee HR, Roh GS. Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer's Disease. Antioxidants (Basel) 2021;10:1657. [PMID: 34829528 DOI: 10.3390/antiox10111657] [Reference Citation Analysis]
8 Behl T, Madaan P, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Chigurupati S, Alrashdi I, Bungau SG. Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target. Int J Mol Sci 2021;22:10161. [PMID: 34576325 DOI: 10.3390/ijms221810161] [Reference Citation Analysis]
9 Karthika C, Appu AP, Akter R, Rahman MH, Tagde P, Ashraf GM, Abdel-Daim MM, Hassan SSU, Abid A, Bungau S. Potential innovation against Alzheimer's disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery. Environ Sci Pollut Res Int 2022;29:10950-65. [PMID: 35000160 DOI: 10.1007/s11356-021-17830-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Jansen JA, Omuro A, Lucca LE. T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies. Curr Opin Neurol 2021;34:827-33. [PMID: 34569985 DOI: 10.1097/WCO.0000000000000988] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tripathi R, Gupta R, Sahu M, Srivastava D, Das A, Ambasta RK, Kumar P. Free radical biology in neurological manifestations: mechanisms to therapeutics interventions. Environ Sci Pollut Res Int 2021. [PMID: 34617231 DOI: 10.1007/s11356-021-16693-2] [Reference Citation Analysis]
12 Liang Y, Xie S, He Y, Xu M, Qiao X, Zhu Y, Wu W, Han J. Kynurenine Pathway Metabolites as Biomarkers in Alzheimer’s Disease. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/9484217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 Sever B, Ciftci H, DeMirci H, Sever H, Ocak F, Yulug B, Tateishi H, Tateishi T, Otsuka M, Fujita M, Başak AN. Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. Int J Mol Sci 2022;23:2400. [PMID: 35269543 DOI: 10.3390/ijms23052400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sorrentino S, Polini A, Arima V, Romano A, Quattrini A, Gigli G, Mozetic P, Moroni L. Neurovascular signals in amyotrophic lateral sclerosis. Curr Opin Biotechnol 2021;74:75-83. [PMID: 34800850 DOI: 10.1016/j.copbio.2021.10.021] [Reference Citation Analysis]